Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medigen Biotechnology Corporation (3176) Financial Statements

Medigen Biotechnology Corporation Financial Overview

Medigen Biotechnology Corporation's market cap is currently NT$4.62B. The company's EPS TTM is NT$-1.82; its P/E ratio is -16.84; Medigen Biotechnology Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.58BNT$ 1.37BNT$ 1.16BNT$ 1.06BNT$ 3.92B
Gross ProfitNT$ 857.73MNT$ 753.76MNT$ 617.33MNT$ 73.07MNT$ 2.53B
Operating IncomeNT$ -156.99MNT$ -210.72MNT$ -1.23BNT$ -1.67BNT$ 789.20M
EBITDANT$ 18.64MNT$ 98.91MNT$ -1.04BNT$ -1.64BNT$ 1.35B
Net IncomeNT$ -108.80MNT$ -204.69MNT$ -561.30MNT$ -675.87MNT$ -52.61M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.50BNT$ 2.59BNT$ 4.59BNT$ 5.07BNT$ 3.00B
Total AssetsNT$ 6.18BNT$ 6.71BNT$ 8.53BNT$ 9.98BNT$ 8.20B
Total DebtNT$ 952.79MNT$ 1.07BNT$ 2.91BNT$ 2.81BNT$ 1.04B
Net DebtNT$ -370.80MNT$ -319.28MNT$ 688.74MNT$ 768.60MNT$ -1.11B
Total LiabilitiesNT$ 1.46BNT$ 1.67BNT$ 3.53BNT$ 3.51BNT$ 1.77B
Stockholders' EquityNT$ 1.55BNT$ 1.58BNT$ 1.59BNT$ 2.19BNT$ 2.39B
Cash Flow
Free Cash FlowNT$ -22.41MNT$ -20.76MNT$ -545.42MNT$ -1.28BNT$ 372.90M
Operating Cash FlowNT$ 49.03MNT$ 37.92MNT$ -503.52MNT$ -1.13BNT$ 517.45M
Investing Cash FlowNT$ 44.34MNT$ 903.30MNT$ 497.66MNT$ -692.67MNT$ -369.75M
Financing Cash FlowNT$ -157.26MNT$ -1.77BNT$ 193.15MNT$ 1.72BNT$ -209.29M

Currency in TWD

Medigen Biotechnology Corporation Earnings and Revenue History

-2.5B02.5B5B-120 %-80 %-40 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Medigen Biotechnology Corporation Liabilities to Assets

04B8B12B20 %30 %40 %50 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Medigen Biotechnology Corporation Cash Flow

-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Medigen Biotechnology Corporation Forecast EPS vs Actual EPS

-1-0.8-0.6-0.4-0.200.2Q2 25Q3 25Q4 25Q2 26Q3 26EPS EstimateBeatMiss
Earnings >